Drug intelligence / Profile preview

oren-to

Development stage
Unknown
Lead developer
Tsumura
Administration
Oral
01

Overview

Oren-to is a traditional Japanese Kampo medicine (herbal formula) composed of seven medicinal herbs: Coptis Rhizome, Glycyrrhiza, Ginger, Jujube, Ginseng, Cinnamon Bark, and Pinellia Tuber. It is traditionally indicated for the treatment of inflammatory conditions of the gastrointestinal tract, including stomatitis, gastritis, and vomiting. In modern clinical research, particularly in Japan, it is being investigated for its potential to prevent or mitigate the severity of radiation-induced oral mucositis in patients undergoing treatment for head and neck cancer. The formula's therapeutic effects are attributed to its complex polypharmacology, which includes anti-inflammatory and cytoprotective actions. Key active constituents, such as berberine from Coptis Rhizome and glycyrrhizin from Glycyrrhiza, are thought to inhibit the production of pro-inflammatory cytokines like TNF-alpha and IL-6, thereby protecting the mucosal lining from oxidative and inflammatory damage.

Brand names
Tsumura Orento Extract Granules
Other names
OrentoHuang-Lian-Tang
02

Targets

TNFA (Tumor necrosis factor alpha (soluble))PTGS2 (Prostaglandin-Endoperoxide Synthase 2)IL-6 (Interleukin 6)

Beyond the preview

Go deeper on oren-to.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on oren-to.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call